Hospital Clínic Barcelona has commemorated the 50th anniversary of the first allogeneic bone marrow transplant performed at the institution, a milestone that marked the beginning of a pioneering program that has played a decisive role in the development and consolidation of this procedure in Spain.
The event, held at the Auditorium of the Faculty of Medicine and Health Sciences of the University of Barcelona, brought together healthcare professionals, researchers, and patients to review the evolution and impact of hematopoietic transplantation over the past five decades.
Among the speakers was Josep Carreras, President of the Josep Carreras Leukaemia Foundation, who highlighted the importance of bone marrow transplantation in the fight against leukaemia and other malignant blood disorders, as well as the essential role of research and donor solidarity in continuing to improve patients’ chances of recovery.
The event also featured Dr. Enric Carreras, former Director of the Hematopoietic Transplant Program at Hospital Clínic and former Director of the Bone Marrow Donor Registry (REDMO) at the Josep Carreras Leukaemia Foundation. He provided a historical perspective on the beginnings of transplantation at the hospital and the evolution of a therapy that has helped save thousands of lives.
During the event, participants recalled that since the first transplant performed in 1976, Hospital Clínic has carried out 3,674 hematopoietic stem cell transplants, of which 1,860 have been allogeneic. The hospital has become a national and international reference center in this field, driving advances that have expanded treatment options and significantly improved patient survival and quality of life.
The commemoration also served to highlight the future challenges of hematopoietic transplantation and the need to continue promoting research in order to develop increasingly effective and safer treatments.